Ann Cohen
CIK: 0001923843
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NAGE
Niagen Bioscience, Inc.
Director
Discretionary Trading P&L
Holdings
About Cohen Ann
Cohen Ann (SEC CIK 0001923843) files insider reports with the SEC as Director of Niagen Bioscience, Inc. (NAGE).
Signal8 holds 2 ownership filings by Cohen Ann, all Form 4s, filed between Jun 25, 2025 and Jun 26, 2026. Those filings report 2 transactions, from Jun 24, 2025 to Jun 24, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Cohen Ann's filings is in LOS ANGELES, CA.
Recent filings by Cohen Ann
Other insiders filing for Niagen Bioscience, Inc. (NAGE)
- Lopez Carlos Luis, SVP, General Counsel
- Pamir Ozan, Chief Financial Officer
- Fried Robert N, Chief Executive Officer
- YU Wing Tak Wendy, Director
- Ng Wang Yu Gary, Director
- Patrick Kristin, Director